First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018

Abstract Objective To assess the first-year features of patients with chronic nonbacterial osteomyelitis (CNO). Methods Patients with a diagnosis of CNO, disease duration of under 13 months, and first registration in the German National Pediatric Rheumatologic Database (NPRD) between 2009 and 2018 w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christiane Reiser, Jens Klotsche, Anton Hospach, Rainer Berendes, Anja Schnabel, Annette F. Jansson, Markus Hufnagel, Nadine Grösch, Martina Niewerth, Kirsten Minden, Hermann Girschick
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/5b740b28a4ed42948593af61e3bdbfa0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5b740b28a4ed42948593af61e3bdbfa0
record_format dspace
spelling oai:doaj.org-article:5b740b28a4ed42948593af61e3bdbfa02021-11-14T12:07:10ZFirst-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 201810.1186/s13075-021-02658-w1478-6362https://doaj.org/article/5b740b28a4ed42948593af61e3bdbfa02021-11-01T00:00:00Zhttps://doi.org/10.1186/s13075-021-02658-whttps://doaj.org/toc/1478-6362Abstract Objective To assess the first-year features of patients with chronic nonbacterial osteomyelitis (CNO). Methods Patients with a diagnosis of CNO, disease duration of under 13 months, and first registration in the German National Pediatric Rheumatologic Database (NPRD) between 2009 and 2018 were included in this cross-sectional analysis. Results Of 774 documented patients, 62.8% were female, and all patients had a median age of 11 years. The most affected clinical sites were the tibia (29.7%), pelvis (28.0%), and femur (27.8%). HLA-B27 was positive in 48 of 314 analyzed patients (15.3%). In 406 patients, an X-ray was performed at the first visit; X-ray results showed osteosclerosis/−lysis in 34.0% and hyperostosis in 14.5% of the patients. MRI scans (focal and whole-body scans) were performed in 648 patients, and 81.5% showed a positive TIRM/STIR signal. A total of 84.7% of the patients were administered nonsteroidal anti-inflammatory drugs, 9.6% were administered oral glucocorticoids, 10.8% were administered disease-modifying anti-rheumatic drugs (DMARDs), and 6.1% were administered bisphosphonates. An evaluation of the patient’s questionnaire showed an overall well-being (NRS 0–10) of 2.0. The PedCNO disease “activity” score revealed a 70% improvement in variables in 43% of patients in the initial 1-year follow-up. Copresentation with diagnostic criteria of pediatric enthesitis-related arthritis was rare. Conclusion To our knowledge, the NPRD cohort seemed to be the largest cohort of children and adolescents suffering from CNO worldwide. Most patients were treated effectively with NSAIDs, and only a small group of patients was administered additional medication. The patient-defined measures of disease activity had a moderate impact on patients’ daily lives. Trial registration Not applicable.Christiane ReiserJens KlotscheAnton HospachRainer BerendesAnja SchnabelAnnette F. JanssonMarkus HufnagelNadine GröschMartina NiewerthKirsten MindenHermann GirschickBMCarticleChronic nonbacterial osteomyelitisPediatric rheumatologyAutoinflammationChronic nonbacterial multifocal osteomyelitisDiseases of the musculoskeletal systemRC925-935ENArthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Chronic nonbacterial osteomyelitis
Pediatric rheumatology
Autoinflammation
Chronic nonbacterial multifocal osteomyelitis
Diseases of the musculoskeletal system
RC925-935
spellingShingle Chronic nonbacterial osteomyelitis
Pediatric rheumatology
Autoinflammation
Chronic nonbacterial multifocal osteomyelitis
Diseases of the musculoskeletal system
RC925-935
Christiane Reiser
Jens Klotsche
Anton Hospach
Rainer Berendes
Anja Schnabel
Annette F. Jansson
Markus Hufnagel
Nadine Grösch
Martina Niewerth
Kirsten Minden
Hermann Girschick
First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
description Abstract Objective To assess the first-year features of patients with chronic nonbacterial osteomyelitis (CNO). Methods Patients with a diagnosis of CNO, disease duration of under 13 months, and first registration in the German National Pediatric Rheumatologic Database (NPRD) between 2009 and 2018 were included in this cross-sectional analysis. Results Of 774 documented patients, 62.8% were female, and all patients had a median age of 11 years. The most affected clinical sites were the tibia (29.7%), pelvis (28.0%), and femur (27.8%). HLA-B27 was positive in 48 of 314 analyzed patients (15.3%). In 406 patients, an X-ray was performed at the first visit; X-ray results showed osteosclerosis/−lysis in 34.0% and hyperostosis in 14.5% of the patients. MRI scans (focal and whole-body scans) were performed in 648 patients, and 81.5% showed a positive TIRM/STIR signal. A total of 84.7% of the patients were administered nonsteroidal anti-inflammatory drugs, 9.6% were administered oral glucocorticoids, 10.8% were administered disease-modifying anti-rheumatic drugs (DMARDs), and 6.1% were administered bisphosphonates. An evaluation of the patient’s questionnaire showed an overall well-being (NRS 0–10) of 2.0. The PedCNO disease “activity” score revealed a 70% improvement in variables in 43% of patients in the initial 1-year follow-up. Copresentation with diagnostic criteria of pediatric enthesitis-related arthritis was rare. Conclusion To our knowledge, the NPRD cohort seemed to be the largest cohort of children and adolescents suffering from CNO worldwide. Most patients were treated effectively with NSAIDs, and only a small group of patients was administered additional medication. The patient-defined measures of disease activity had a moderate impact on patients’ daily lives. Trial registration Not applicable.
format article
author Christiane Reiser
Jens Klotsche
Anton Hospach
Rainer Berendes
Anja Schnabel
Annette F. Jansson
Markus Hufnagel
Nadine Grösch
Martina Niewerth
Kirsten Minden
Hermann Girschick
author_facet Christiane Reiser
Jens Klotsche
Anton Hospach
Rainer Berendes
Anja Schnabel
Annette F. Jansson
Markus Hufnagel
Nadine Grösch
Martina Niewerth
Kirsten Minden
Hermann Girschick
author_sort Christiane Reiser
title First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
title_short First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
title_full First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
title_fullStr First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
title_full_unstemmed First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
title_sort first-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the german national pediatric rheumatologic database from 2009 to 2018
publisher BMC
publishDate 2021
url https://doaj.org/article/5b740b28a4ed42948593af61e3bdbfa0
work_keys_str_mv AT christianereiser firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT jensklotsche firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT antonhospach firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT rainerberendes firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT anjaschnabel firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT annettefjansson firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT markushufnagel firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT nadinegrosch firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT martinaniewerth firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT kirstenminden firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
AT hermanngirschick firstyearfollowupofchildrenwithchronicnonbacterialosteomyelitisananalysisofthegermannationalpediatricrheumatologicdatabasefrom2009to2018
_version_ 1718429404465463296